4.79

0.00% 0.00

Aldeyra Therapeutics Inc (ALDX)

Überblick Nachrichten Preisverlauf Optionskette Financials Forum Prognose

Schlusskurs vom Vortag:

$4.79

Offen:

$4.77

24-Stunden-Volumen:

838.36K

Relative Volume:

1.09

Marktkapitalisierung:

$288.18M

Einnahmen:

Nettoeinkommen (Verlust:

$-44.80M

KGV:

-6.3867

EPS:

-0.75

Netto-Cashflow:

$-30.67M

1W Leistung:

-1.64%

1M Leistung:

-6.63%

6M Leistung:

+78.40%

1J Leistung:

-9.45%

1-Tages-Spanne:

$4.675

$4.81

1-Wochen-Bereich:

$4.67

$5.04

52-Wochen-Spanne:

$1.14

$7.20

Aldeyra Therapeutics Inc Stock (ALDX) Company Profile

Firmenname

Aldeyra Therapeutics Inc

Sektor

Healthcare (1124)

Branche

Biotechnology (627)

Telefon

781-761-4904

Adresse

131 HARTWELL AVENUE, LEXINGTON, MA

Mitarbeiter

Twitter

@aldeyraaldx

Nächster Verdiensttermin

2025-08-08

Neueste SEC-Einreichungen

ALDX's Discussions on Twitter

Vergleichen Sie ALDX mit anderen Aktien

Aktien	Preis	Marktkapitalisierung	Umsatz	Nettogewinn	Free Cashflow	ENV
ALDX Aldeyra Therapeutics Inc	4.79	288.18M	0	-44.80M	-30.67M	-0.75
VRTX Vertex Pharmaceuticals Inc	444.64	110.88B	11.74B	3.68B	3.34B	14.19
REGN Regeneron Pharmaceuticals Inc	726.21	72.79B	14.25B	4.58B	3.88B	41.77
ARGX Argen X Se Adr	890.11	54.76B	3.06B	1.28B	447.35M	19.67
ALNY Alnylam Pharmaceuticals Inc	404.46	54.85B	3.21B	43.57M	221.36M	0.2405
INSM Insmed Inc	189.85	41.41B	447.02M	-1.18B	-906.14M	-6.1812

Aldeyra Therapeutics Inc Stock (ALDX) Upgrades & Downgrades

Datum	Aktion	Analytiker	Ratingänderung
2024-04-03	Hochstufung	Oppenheimer	Perform → Outperform
2024-04-02	Fortgesetzt	H.C. Wainwright	Buy
2022-04-27	Fortgesetzt	H.C. Wainwright	Buy
2021-02-08	Eingeleitet	H.C. Wainwright	Buy
2020-12-16	Eingeleitet	Berenberg	Buy
2020-10-30	Eingeleitet	Jefferies	Buy
2020-10-16	Eingeleitet	BTIG Research	Buy
2020-09-22	Eingeleitet	Alliance Global Partners	Buy
2020-05-12	Eingeleitet	Oppenheimer	Outperform
2018-12-04	Eingeleitet	Citigroup	Buy
2018-09-26	Bestätigt	Cantor Fitzgerald	Overweight
2018-09-13	Eingeleitet	Janney	Buy
2018-01-26	Eingeleitet	Seaport Global Securities	Buy
2016-09-26	Eingeleitet	H.C. Wainwright	Buy
2016-07-01	Eingeleitet	Stifel	Buy
2015-07-01	Eingeleitet	Canaccord Genuity	Buy
2015-03-25	Eingeleitet	Chardan Capital Markets	Buy
2015-03-20	Bestätigt	H.C. Wainwright	Buy
2014-11-18	Eingeleitet	H.C. Wainwright	Buy
2014-06-19	Eingeleitet	Aegis Capital	Buy

Alle ansehen

Aldeyra Therapeutics Inc Aktie (ALDX) Neueste Nachrichten

Dec 10, 2025

Adversity is less terrifying than hope: Aldeyra Therapeutics Inc (ALDX) - Setenews

Dec 10, 2025

Dec 08, 2025

Aldeyra Therapeutics, Inc.'s (NASDAQ:ALDX) recent 10% pullback adds to one-year year losses, institutional owners may take drastic measures - Yahoo Finance

Dec 08, 2025

Dec 06, 2025

Winners Losers: Will Aldeyra Therapeutics Inc stock maintain momentum in 2025 - BỘ NỘI VỤ

Dec 06, 2025

Dec 03, 2025

It makes sense and dollars to buy Aldeyra Therapeutics Inc (ALDX) stock - Setenews

Dec 03, 2025

Dec 02, 2025

Aldeyra Therapeutics Inc (137.DU) Stock Price, News, Quote & History - Yahoo! Finance Canada

Dec 02, 2025

Is Aldeyra Therapeutics Inc. stock oversold or undervaluedCEO Change & Smart Allocation Stock Reports - Newser

Dec 02, 2025

Nov 28, 2025

Will Aldeyra Therapeutics Inc. stock maintain momentum in 2025Bull Run & Free Technical Confirmation Trade Alerts - BỘ NỘI VỤ

Nov 28, 2025

Nov 27, 2025

Can Aldeyra Therapeutics Inc. stock deliver surprise earnings beatChart Signals & Long-Term Capital Growth Strategies - moha.gov.vn

Nov 27, 2025

Will Aldeyra Therapeutics Inc. stock benefit from infrastructure spendingJuly 2025 Analyst Calls & Fast Entry and Exit Trade Plans - moha.gov.vn

Nov 27, 2025

Does Aldeyra Therapeutics (NASDAQ:ALDX) Have A Healthy Balance Sheet? - simplywall.st

Nov 27, 2025

Nov 21, 2025

Why retail investors favor Aldeyra Therapeutics Inc. stock2025 Short Interest & Free Growth Oriented Trading Recommendations - newser.com

Nov 21, 2025

Nov 20, 2025

Aldeyra Therapeutics Inc Stock Analysis and ForecastContrarian Investment Ideas & Small Investment Trading Tips - earlytimes.in

Nov 20, 2025

The time has not yet come to remove your chips from the table: Aldeyra Therapeutics Inc (ALDX) - Setenews

Nov 20, 2025

Dry Eye Disease Market Size was ~USD 3.76 Billion in 2023 and expected to Grow by 2034, Analysed DelveInsight - Barchart.com

Nov 20, 2025

HC Wainwright Has Bullish Estimate for ALDX FY2025 Earnings - Defense World

Nov 20, 2025

What sentiment indicators say about Aldeyra Therapeutics Inc. stockJuly 2025 News Drivers & AI Based Buy/Sell Signal Reports - newser.com

Nov 20, 2025

Nov 19, 2025

Intraday pattern recognizer results for Aldeyra Therapeutics Inc.July 2025 Closing Moves & Daily Profit Maximizing Trade Tips - newser.com

Nov 19, 2025

Aldeyra Therapeutics Inc. stock daily chart insightsTrend Reversal & AI Forecast Swing Trade Picks - newser.com

Nov 19, 2025

Understanding Aldeyra Therapeutics Inc.’s price movement - newser.com

Nov 19, 2025

Live market analysis of Aldeyra Therapeutics Inc.CEO Change & Short-Term High Return Ideas - newser.com

Nov 19, 2025

How Aldeyra Therapeutics Inc. stock performs in weak economyGap Down & Weekly Market Pulse Alerts - newser.com

Nov 19, 2025

Why Aldeyra Therapeutics Inc. stock is in analyst buy zonePortfolio Update Summary & High Conviction Buy Zone Alerts - newser.com

Nov 19, 2025

Can a trend reversal in Aldeyra Therapeutics Inc. lead to recoveryPortfolio Risk Report & Fast Exit and Entry Trade Guides - newser.com

Nov 19, 2025

Applying Wyckoff theory to Aldeyra Therapeutics Inc. stock2025 Market Trends & Daily Growth Stock Investment Tips - newser.com

Nov 19, 2025

Brokers Offer Predictions for ALDX Q1 Earnings - Defense World

Nov 19, 2025

What candlestick patterns are forming on Aldeyra Therapeutics Inc.Market Growth Report & Risk Managed Trade Strategies - newser.com

Nov 19, 2025

Nov 17, 2025

Aldeyra Therapeutics Inc.’s volatility index tracking explainedMarket Performance Recap & Real-Time Volume Surge Alerts - newser.com

Nov 17, 2025

Nov 16, 2025